green
Positive treatment
3.9 score
Treatment trajectory · 2000 → 2026 · click a year to view as-of
2000
2013
2026
Top citers, strongest first. 7 distinct citers.
cited
Cited "see"
Commonwealth v. Miranda
See United States v. Levenite, 277 F.3d 454, 462-463 (4th Cir.), cert, denied, 535 U.S. 1105 (2002).
discussed
Cited "see"
United States v. Coplin
See United States v. Buckland, 277 F.3d 1173 (9th Cir.2002) (en banc), amended and superseded by United States v. Buckland, 289 F.3d 558 (9th Cir.2002) (en banc), cert. denied, 535 U.S. 1105 , 122 S.Ct. 2314 , 152 L.Ed.2d 1067 (2002). 7 While Coplin’s reliance on Buckland is easily dismissed, his argument raises the more interesting question whether Coplin has a nonfrivolous ground for appeal based on the Supreme Court’s recent decision in Blakely v. Washington, — U.S.-, 124 S.Ct. 2531 , 159 L.Ed.2d 403 (2004), rendered after the filing of the briefs in this case.
cited
Cited "see"
United States v. Wilson
See United States v. Daniels, 281 F.3d 168, 183 (5th Cir.), cert. denied, 535 U.S. 1105 , 122 S.Ct. 2313 , 152 L.Ed.2d 1067 (2002).
discussed
Cited "see"
United States v. Hollingsworth
See United States v. Buckland, 277 F.3d 1173 (9th Cir.2002) (en banc), as amended and superceded by 289 F.3d 558 and cert. denied, 535 U.S. 1105 , 122 S.Ct. 2314 , 152 L.Ed.2d 1067 (2002) (§ 841); United States v. Mendoza-Paz, 286 F.3d 1104, 1110 (9th Cir.2002), cert. denied, ___ U.S. ___, 123 S.Ct. 573 , 154 L.Ed.2d 459 (2002) (§ 960); United States v. Varela-Rivera, 279 F.3d 1174 , 1175 n. 1 (9th Cir.2002) (§ 952).
discussed
Cited "see"
United States v. Gann (Ralph)
See United States v. Buckland, 289 F.3d 558, 570-71 (9th Cir.) (en banc) (stating that Apprendi is not violated when district court applies Guideline § 5G1.2(d) to issue consecutive sentences under multiple counts in order to reach an appropriate total sentence under the Guidelines so long as no sentence under any one count exceeds the maximum allowable under Apprendi for that count in the absence of a jury determination of drug quantities that would support an enhanced sentence under that count), cert. denied, 535 U.S. 1105 , 122 S.Ct. 2314 , 152 L.Ed.2d 1067 (2002).
discussed
Cited "see, e.g."
Moreland v. Federal Bureau of Prisons
(2×)
Id.; see also Pacheco-Camacho v. Hood, 272 F.3d 1266, 1268-69 (9th Cir.2001), cert. denied, 535 U.S. 1105 , 122 S.Ct. 2313 , 152 L.Ed.2d 1067 (2002) ("Whereas the model prisoner will ordinarily receive his fifty-four-day credit after complying with prison disciplinary rules for 365 days, under [the prisoner’s] reading, a prisoner who serves 311 days would receive the same number of credits for exhibiting good behavior over only eighty-five percent of the year.”). .
discussed
Cited "see, e.g."
United States v. Francisco Javier Alvarez, A.K.A. Frank Javier Alvarez, United States of America v. Richard Valenzuela
See, e.g., United States v. Buckland, 289 F.3d 558, 562 (9th Cir.) (en banc) (rejecting facial challenge to 21 U.S.C. § 841 , which does not specify who shall determine drug quantity or identify the appropriate burden of proof), cert. denied, 535 U.S. 1105 , 122 S.Ct. 2314 , 152 L.Ed.2d 1067 (2002); United States v. Romero, 282 F.3d 683, 690 (9th Cir.) (rejecting Apprendi challenge to district judge’s determination of drug quantity because the resulting sentence did not exceed the maximum sentence authorized by the jury’s verdict), cert. denied, 537 U.S. 858 , 123 S.Ct. 228 , 154 L.Ed.2d …
Boyd
v.
T'kach
v.
T'kach
01-9767.
Supreme Court of the United States.
May 28, 2002.
Published
BOYD
v.
T'KACH.
No. 01-9767.
Supreme Court of the United States.
May 28, 2002.
1
C. A. 10th Cir. Certiorari denied. Reported below: 26 Fed. Appx. 792.